Vanguards Skyline Holdings Limited Plans to Sell Ordinary Shares of Zhengye Biotechnology Holding Limited

Vanguards Skyline Holdings Limited has filed a Form 144 with the SEC, indicating its intention to sell 2,278,752 ordinary shares of Zhengye Biotechnology Holding Limited. The shares were acquired on June 21, 2023, and the planned sale is expected to occur around November 1, 2025. The aggregate market value of the shares to be sold is approximately $29,419,666. The shares are listed on NASDAQ, and the transaction will be facilitated by AC Sunshine Securities LLC. The filing also confirms that there have been no sales of securities by Vanguards Skyline Holdings Limited in the past three months.